Stryker will pay approximately $701 million for NOVADAQ Technologies, a Canadian maker of fluorescent imaging technology for blood flow visualization, in a definitive deal that represents a 96% premium on NOVADAQ's closing share price on June 16. The acquisition, which is expected to be completed at the end of the third quarter, is subject to approval by NOVADAQ shareholders and other customary closing conditions.
Stryker enters $701M deal to buy Canadian imaging technology firm
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.